Ultragenyx Pharmaceutical | Umlaufvermögen

Aktienkurs
22.73
Täglich Wechseln
0.90 4.12%
Monatlich
-0.09%
Jährlich
-46.63%
Q1 Prognose
19.88




Umlaufvermögen Veränderung Datum
Acadia Pharmaceuticals USD 1.08B 115.87M 2025-09
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Immunic USD 39.27M 20.57M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Kyowa Hakko Kirin JPY 493.35B 2.55B 2025-12
MacroGenics USD 232.09M 27.15M 2025-09
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09


Ultragenyx Pharmaceutical Umlaufvermögen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.